Patterns of human leukocyte antigen class I and class II associations and cancer Journal Article


Authors: Liu, Z.; Derkach, A.; Yu, K. J.; Yeager, M.; Chang, Y. S.; Chen, C. J.; Gyllensten, U.; Lan, Q.; Lee, M. H.; McKay, J. D.; Rothman, N.; Yang, H. I.; Hildesheim, A.; Pfeiffer, R. M.
Article Title: Patterns of human leukocyte antigen class I and class II associations and cancer
Abstract: Human leukocyte antigen (HLA) gene variation is associated with risk of cancers, particularly those with infectious etiology or hematopoietic origin, given its role in immune presentation. Previous studies focused primarily on HLA allele/haplotype-specific associations. To answer whether associations are driven by HLA class I (essential for T-cell cytotoxicity) or class II (important for T-cell helper responses) genes, we analyzed GWAS from 24 case–control studies and consortia comprising 27 cancers (totaling >71,000 individuals). Associations for most cancers with infectious etiology or of hematopoietic origin were driven by multiple HLA regions, suggesting that both cytotoxic and helper T-cell responses are important. Notable exceptions were observed for nasopharyngeal carcinoma, an EBV-associated cancer, and CLL/SLL forms of non-Hodgkin lymphomas; these cancers were associated with HLA class I region only and HLA class II region only, implying the importance of cytotoxic T-cell responses for the former and CD4þ T-cell helper responses for the latter. Our findings suggest that increased understanding of the pattern of HLA associations for individual cancers could lead to better insights into specific mechanisms involved in cancer pathogenesis. Significance: GWAS of >71,000 individuals across 27 cancer types suggest that patterns of HLA Class I and Class II associations may provide etiologic insights for cancer. ©2020 American Association for Cancer Research.
Keywords: controlled study; human cell; major clinical study; case control study; genome-wide association study; carcinogenesis; nonhodgkin lymphoma; hla antigen class 2; cd4+ t lymphocyte; cytotoxic t lymphocyte; hla antigen class 1; nasopharynx carcinoma; chronic lymphatic leukemia; epstein barr virus; helper cell; hla system; human; priority journal; article; malignant neoplasm; lymphocytic lymphoma
Journal Title: Cancer Research
Volume: 81
Issue: 4
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-02-15
Start Page: 1148
End Page: 1152
Language: English
DOI: 10.1158/0008-5472.Can-20-2292
PROVIDER: scopus
PUBMED: 33272927
PMCID: PMC9986718
DOI/URL:
Notes: Article -- Export Date: 1 April 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andriy Derkach
    148 Derkach